GlassScriptPhysician profile
Stephen Pirotta
NPI 1053311944
$4,498.39
in general payments reported to CMS, 2019-2025
24 companies · $639 in 2025
The $639 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $535 · 2021: $511 · 2022: $296 · 2023: $1,103 · 2024: $831 · 2025: $639.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,641 · Travel and Lodging: $932.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.92 |
| Travel and Lodging | $931.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $1,539.36 | 2019-2023 | Krystexxa |
| Treace Medical Concepts, INC. | $1,165.37 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $458.31 | 2020-2025 | Nuzyra, Xhance |
| Kowa Pharmaceuticals America, INC. | $255.32 | 2022-2023 | Seglentis |
| Organogenesis INC. | $173.03 | 2021-2024 | Puraply Wound Matrix, Matrix, Affinity |
| Amgen INC. | $147.97 | 2024-2025 | Krystexxa |
| Melinta Therapeutics, LLC | $82.81 | 2023-2024 | Orbactiv, Kimyrsa |
| Vertex Pharmaceuticals Incorporated | $78.93 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $75.95 | 2021 | |
| Averitas Pharma INC. | $64.09 | 2024-2025 | Qutenza |
| Abbvie INC. | $62.77 | 2021-2023 | |
| Nevro Corp. | $59.57 | 2024 | Senza |
| Depuy Synthes Sales INC. | $40.18 | 2025 | Motoband |
| Stryker Corporation | $38.31 | 2019 | |
| Zyla Life Sciences, INC. | $37.41 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $33.85 | 2025 | Purified Cortrophin Gel |
| Bioventus LLC | $31.43 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Globus Medical, INC. | $29.16 | 2025 | Omnia |
| Merck Sharp & Dohme LLC | $27.20 | 2019 | |
| Solventum Corporation | $26.53 | 2025 | Activ.A.C. |
| Djo, LLC | $26.49 | 2024 | Cmf |
| Grt US Holding, INC. | $18.79 | 2021 | |
| Smith+Nephew, INC. | $13.38 | 2022 | |
| Osiris Therapeutics INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Pirotta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.